** Shares of Clarity Pharmaceuticals CU6.AX jumps 12.4% to A$1.885, highest since April 3
** The radiopharmaceutical company gets R&D tax incentive refund to develop its Targeted Copper Theranostic (TCT) platform to diagnose and treat various cancers
** Co also signs deal for supply of copper-64 isotope, which is used along with copper-67 in TCT platforms
** Despite the day's gains, the stock is down about 55% YTD
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.